REDHILL BIOPHARMA LTD-SP ADR
RDHLNASDAQ🏆 #4051 by market capEarnings Aug 20US Equity
$0.60▲ $0.02 (+3.27%)
Market closed · at close1h—
24h▲ 3.3%
7d▼ 13.0%
14d▼ 13.0%
30d▼ 14.3%
1y▼ 54.9%
🏦Market Cap
$36.49B
Mid Cap
📈Revenue Growth (YoY)
-58.9%
Declining
📊Gross Margin
60.4%
High
💵FCF Margin
—
⚖️P/S Ratio
0.8x
Cheap
Otter Score
45
Weak
Earnings
Q3 · 2025Reported 2025-09-05Earnings Per Share
Actual
-1.00
Expected
-690.00
beat
+99.90%
YoY +50.00%
Revenue
Actual
$2.04M
Expected
$4.38M
miss
−53.40%
YoY +58.60%
Consensus estimates
Recent quarters
Q3 2025
-1.00
beat
Q2 2025
-1.00
beat
Q4 2024
-1.00
beat
Q3 2024
-2.00
miss